Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients

NCT04304352 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Vinorelbine
DRUG: Capecitabine
DRUG: Cyclophosphamide

Sponsor

European Institute of Oncology